HOME > NATION > Article

Text Size

small

medium

large


90 Pct Develop Antibodies for Variants after 2 Pfizer Jabs

90 Pct Develop Antibodies for Variants after 2 Pfizer Jabs

   Tokyo, May 12 (Jiji Press)--Some 90 pct of people who have received two jabs of the novel coronavirus vaccine from Pfizer Inc. developed neutralizing antibodies against variant strains, a Japanese research team said Wednesday.
   The proportion of those who acquired such antibodies after being administered their first shots was relatively low, according to the team, led by Takeharu Yamanaka, professor at Yokohama City University.
   "The finding gives hope for herd immunity," Yamanaka said. "We may be able to deal with the existing variants with the vaccines we have now."
   The survey covered 105 staff members of the university's hospital with no record of coronavirus infection who were given the Pfizer vaccine, and the team studied the proportion of people who developed neutralizing antibodies against seven mutant strains, including those originating from British and South Africa, and the conventional strain.
   Whereas only 18 pct of those after their first jabs had antibodies that can fend off infections with the British variant, 94 pct had the antibodies after their second jabs.

To read a full story, please click here to find out how to subscribe.

NATION

Aomori Tourism Information

HEADLINES

POLITICS
US, EU Agree to Mutually Suspend Aircraft Subsidy Retaliatory Tariffs for 5 Yrs
ECONOMY
Japan's Exports Up 49.6% Yr/Yr in May, Second-Biggest Rise on Record
SPORTS
Japan Baseball: 24 Tokyo Olympic Members Including Masahiro Tanaka Picked
OTHER
Novel Coronavirus Death Toll in US Reaches 600,000: Johns Hopkins University

AFP-JIJI PRESS NEWS JOURNAL


Photos